Renal medullary carcinomas: Histopathologic phenotype associated with diverse genotypes

Human Pathology

Volumn 42, Issue 12, 2011, Pages 1979-1988

  Gatalica, Zoran ^a   Lilleberg, Stan L ^b   Monzon, Federico A ^c,d   Koul, Manika Sapru ^b   Bridge, Julia A ^e   Knezetic, Joseph ^a   Legendre, Ben ^b   Sharma, Poonam ^a   McCue, Peter A ^f  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TRANSGENOMIC INC   (United States)

^c HOUSTON METHODIST HOSPITAL   (United States)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

^e UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^f THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

Author keywords

Hypoxia induced signaling; Karyotype; Kidney; Medullary Carcinoma; Oncogenes

Indexed keywords

ANTINEOPLASTIC AGENT; FUMARATE HYDRATASE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; VON HIPPEL LINDAU PROTEIN;

ABDOMINAL PAIN; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CASE REPORT; CHROMOSOME ABERRATION; CYTOGENETICS; DEEP VEIN THROMBOSIS; EPIGENETICS; EXON; FLANK PAIN; GENOTYPE PHENOTYPE CORRELATION; GERM LINE; HEMATURIA; HUMAN; KIDNEY CARCINOMA; LIMB PAIN; LYMPHADENOPATHY; MALE; NEPHRECTOMY; RENAL MEDULLARY CARCINOMA; RETROPERITONEAL LYMPHADENOPATHY; SICKLE CELL ANEMIA; SINGLE NUCLEOTIDE POLYMORPHISM; SOMATIC MUTATION; TUMOR BIOPSY; WEDGE RESECTION;

ADULT; ANEMIA, SICKLE CELL; CARCINOMA, MEDULLARY; CARCINOMA, RENAL CELL; CHROMOSOME ABERRATIONS; DNA MUTATIONAL ANALYSIS; EXONS; FATAL OUTCOME; FUMARATE HYDRATASE; GENOTYPE; GERM-LINE MUTATION; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; KARYOTYPE; KIDNEY NEOPLASMS; MALE; MICROSATELLITE INSTABILITY; MUTATION; PHENOTYPE; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

EID: 80955133849     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2011.02.026     Document Type: Article

References (43)

1. C.J. Davis Jr, F.K. Mostofi, and I.A. Sesterhenn Renal medullary carcinoma. The seventh sickle cell nephropathy Am J Surg Pathol 19 1995 1 11
2. R.A. Avery, J.E. Harris, C.J. Davis Jr, D.S. Borgaonkar, J.C. Byrd, and R.B. Weiss Renal medullary carcinoma: clinical and therapeutic aspects of a newly described tumor Cancer 78 1996 128 132 (Pubitemid 26189912)
3. P.H. O'Donnell, A. Jensen, and E.M. Posadas Renal medullary-like carcinoma in an adult without sickle cell hemoglobinopathy Nat Rev Urol 7 2010 110 114
4. M.A. Swartz, J. Karth, D.T. Schneider, R. Rodriguez, J.B. Beckwith, and E.J. Perlman Renal medullary carcinoma: clinical, pathologic, immunohistochemical, and genetic analysis with pathogenetic implications Urology 60 2002 1083 1089 (Pubitemid 35447572)
5. G. Kovacs, M. Akhtar, and B.J. Beckwith The Heidelberg classification of renal cell tumours J Pathol 183 1997 131 133
6. B. Delahunt, M. Velickovic, and S.K. Grebe Evolving classification of renal cell neoplasia Expert Rev Anticancer Ther 1 2001 576 584 (Pubitemid 34679449)
7. K.A. Furge, K.A. Lucas, and M. Takahashi Robust classification of renal cell carcinoma based on gene expression data and predicted cytogenetic profiles Cancer Res 64 2004 4117 4121 (Pubitemid 38802413)
8. W.M. Linehan, M.M. Walther, and B. Zbar The genetic basis of cancer of the kidney J Urol 170 2003 2163 2172 (Pubitemid 37413950)
9. W.M. Linehan, J. Vasselli, and R. Srinivasan Genetic basis of cancer of the kidney: disease-specific approaches to therapy Clin Cancer Res 10 2004 6282s 6289s (Pubitemid 39287479)
10. H. Ross, and P. Argani Xp11 translocation renal cell carcinoma Pathology 42 2010 369 373
11. N.A. Alam, S. Olpin, and I.M. Leigh Fumarate hydratase mutations and predisposition to cutaneous leiomyomas, uterine leiomyomas and renal cancer Br J Dermatol 153 2005 11 17 (Pubitemid 41044521)
12. J. Stahlschmidt, C. Cullinane, P. Roberts, and S.V. Picton Renal medullary carcinoma: prolonged remission with chemotherapy, immunohistochemical characterization and evidence of bcr/abl rearrangement Med Pediatr Oncol 33 1999 551 557
13. D. Chatelain, G. de Pinieux, and J. Slama Renal medullary carcinoma, a new clinico-pathologic entity. Immunohistochemical, ultrastructural, flow cytometric and cytogenetic study of a case Ann Pathol 19 1999 320 324 (Pubitemid 29482148)
14. L.V. Debelenko, S.C. Raimondi, and N. Daw Renal cell carcinoma with novel VCL-ALK fusion: new representative of ALK-associated tumor spectrum Mod Pathol 24 2010 430 442 10.1038/modpathol.2010;213
15. X.J. Yang, J. Sugimura, and M.S. Tretiakova Gene expression profiling of renal medullary carcinoma: potential clinical relevance Cancer 100 2004 976 985 (Pubitemid 38222858)
16. L. Fuzesi, M. Cober, and C. Mittermayer Collecting duct carcinoma: cytogenetic characterization Histopathology 21 1992 155 160
17. M.A. Gregori Romero, L. Morell Quadreny, and A. Llombart Bosch Cytogenetic analysis of three primary Bellini duct carcinomas Genes Chromosomes Cancer 15 1996 170 172
18. A.O. Cavazzana, T. Prayer-Galetti, and R. Tirabosco Bellini duct carcinoma. A clinical and in vitro study Eur Urol 30 1996 340 344 (Pubitemid 26362876)
19. I. Verdorfer, Z. Culig, and A. Hobisch Characterisation of a collecting duct carcinoma by cytogenetic analysis and comparative genomic hybridisation Int J Oncol 13 1998 461 464 (Pubitemid 28372667)
20. A. Antonelli, E. Portesi, and A. Cozzoli The collecting duct carcinoma of the kidney: a cytogenetical study Eur Urol 43 2003 680 685 (Pubitemid 36648609)
21. R.S. Bridge Jr, J.A. Bridge, J.R. Neff, S. Naumann, P. Althof, and L.A. Bruch Recurrent chromosomal imbalances and structurally abnormal breakpoints within complex karyotypes of malignant peripheral nerve sheath tumour and malignant triton tumour: a cytogenetic and molecular cytogenetic study J Clin Pathol 57 2004 1172 1178 (Pubitemid 39486524)
22. G. Yamamoto, Y. Nannya, and M. Kato Highly sensitive method for genomewide detection of allelic composition in nonpaired, primary tumor specimens by use of affymetrix single-nucleotide-polymorphism genotyping microarrays Am J Hum Genet 81 2007 114 126 (Pubitemid 47001161)
23. F.A. Monzon, K. Alvarez, and Z. Gatalica Detection of chromosomal aberrations in renal tumors: a comparative study of conventional cytogenetics and virtual karyotyping with SNP microarrays Arch Pathol Lab Med 133 2009 1917 1922
24. H.J. Kim, S.S. Shen, and A.G. Ayala Virtual-karyotyping with SNP microarrays in morphologically challenging renal cell neoplasms: a practical and useful diagnostic modality Am J Surg Pathol 33 2009 1276 1286
25. A.S. Merseburger, J. Hennenlotter, and P. Simon Membranous expression and prognostic implications of epidermal growth factor receptor protein in human renal cell cancer Anticancer Res 2005 251901 251907
26. A.R. von Bergh, E. van Drunen, and E.R. van Wering High incidence of t(7;12)(q36;p13) in infant AML but not in infant ALL, with a dismal outcome and ectopic expression of HLXB9 Genes Chromosomes Cancer 45 2006 731 739
27. G. Steiner, P. Cairns, and T.J. Polascik High-density mapping of chromosomal arm 1q in renal collecting duct carcinoma: region of minimal deletion at 1q32.1-32.2 Cancer Res 56 1996 5044 5046 (Pubitemid 26374447)
28. T.J. Polascik, P. Cairns, and J.I. Epstein Distal nephron renal tumors: microsatellite allelotype Cancer Res 56 1996 1892 1895 (Pubitemid 26118228)
29. M.R. Speicher, B. Schoell, and S. du Manoir Specific loss of chromosomes 1, 2, 6, 10, 13, 17, and 21 in chromophobe renal cell carcinomas revealed by comparative genomic hybridization Am J Pathol 145 1994 356 364 (Pubitemid 24245836)
30. L. Simpson, X. He, and M. Pins Renal medullary carcinoma and ABL gene amplification J Urol 173 2005 1883 1888 (Pubitemid 40675203)
31. H.T. Lynch, R.J. Taylor, and J.F. Lynch Multiple primary cancer, including transitional cell carcinoma of the upper uroepithelial tract in a multigeneration HNPCC family: molecular genetic, diagnostic, and management implications Am J Gastroenterol 98 2003 664 670 (Pubitemid 36348542)
32. N. Kanomata, J.N. Eble, and K.C. Halling Microsatellite instability is uncommon in young patients with renal cell carcinoma Cancer Genet Cytogenet 101 1998 123 127 (Pubitemid 28141173)
33. M.L. Nickerson, E. Jaeger, and Y. Shi Improved identification of von Hippel-Lindau gene alterations in clear cell renal tumors Clin Cancer Res 14 2008 4726 4734
34. L. Schmidt, F.M. Duh, and F. Chen Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas Nat Genet 16 1997 68 73 (Pubitemid 27198158)
35. S. Gad, S.H. Lefèvre, and S.K. Khoo Mutations in BHD and TP53 genes, but not in HNF1beta gene, in a large series of sporadic chromophobe renal cell carcinoma Br J Cancer 96 2007 336 340 (Pubitemid 46160640)
36. I.P. Tomlinson, N.A. Alam, and A.J. Rowan Multiple leiomyoma consortium: germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer Nat Genet 2002 406 410
37. T. Bourgeron, D. Chretien, and J. Poggi-Bach Mutation of the fumarase gene in two siblings with progressive encephalopathy and fumarase deficiency J Clin Invest 93 1994 2514 2518 (Pubitemid 24177166)
38. J.S. Isaacs, Y.J. Jung, and D.R. Mole HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability Cancer Cell 8 2005 143 153 (Pubitemid 41132743)
39. V.H. Haase The VHL/HIF oxygen-sensing pathway and its relevance to kidney disease Kidney Int 69 2006 1302 1307
40. O. Iliopoulos, A.P. Levy, C. Jiang, W.G. Kaelin Jr, and M.A. Goldberg Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein Proc Natl Acad Sci U S A 93 1996 10595 10599 (Pubitemid 26333032)
41. P.H. Maxwell, M.S. Wiesener, and G.W. Chang The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis Nature 399 1999 271 275 (Pubitemid 29246458)
42. A.J. Duits, T. Rodriguez, J.J. Schnog CURAMA Study Group Serum levels of angiogenic factors indicate a pro-angiogenic state in adults with sickle cell disease Br J Haematol 134 2006 116 119 (Pubitemid 43830037)
43. B.I. Rini, M.D. Michaelson, and J.E. Rosenberg Antitumor activity and biomarker analysis of sunitinib in patients with bevacizumab-refractory metastatic renal cell carcinoma J Clin Oncol 26 2008 3743 3748